Nelson Peltz’s Trian Pushes Solventum to Further Simplify Business

Activist investor Trian Fund Management is pushing Solventum SOLV 0.57%increase; green up pointing triangle to separate more of its businesses after the company’s $4.1 billion deal to sell its filtration unit, according to people familiar with the matter.

The details

Nelson Peltz’s firm has held a roughly 5% stake in Solventum since the middle of last year. Solventum, which sells healthcare products, was spun out from 3M in April 2024.